Xryma Plc has unveiled plans to seek readmission to Euronext Paris within the next 12 months, marking another step in its capital markets strategy. Before submitting its application, the company intends to launch a structured pre-listing liquidity and price discovery process that combines a private placement for institutional investors with a voluntary share sale opportunity for existing shareholders. The initiative is designed to establish a market-based valuation while giving investors an easier path to liquidity ahead of a potential public market return.

Xryma Plc has announced its intention to reapply for admission to trading on Euronext Paris, subject to approval by the exchange and relevant financial regulators. While the listing remains contingent on regulatory review, the company plans to complete a pre-listing liquidity program aimed at determining a market-driven share price and facilitating an orderly transition should trading resume.

The proposed process combines two parallel transactions. Xryma intends to conduct a private placement targeting qualified and institutional investors while also allowing existing shareholders to voluntarily sell some or all of their holdings before the planned listing. According to the company, both investor groups would transact at the same reference price established during the institutional placement.

The approach reflects a growing trend among companies preparing for public listings, where structured private financing rounds are increasingly used to validate valuations before entering public markets. Such mechanisms have become more common across European capital markets as issuers seek to reduce pricing uncertainty while attracting long-term institutional investors.

Unlike a conventional pre-IPO financing round, Xryma’s proposal places significant emphasis on shareholder liquidity. Existing investors who wish to exit their positions will not be required to establish brokerage accounts within the European Union, removing what the company describes as an operational hurdle for certain shareholders.

The pricing mechanism will allow participating shareholders to specify a minimum acceptable sale price. If the final institutional placement establishes a higher valuation, their shares would be sold at the final placement price, less any applicable fees. Should demand from buyers or sellers become imbalanced, allocations may be reduced proportionally, resulting in partial execution of submitted orders.

Xryma said the liquidity process will proceed only if institutional investor demand reaches levels that its board considers sufficient to support an orderly aftermarket following a potential Euronext admission. Participation will remain entirely voluntary, allowing shareholders who prefer to retain their holdings to continue doing so.

The company’s two largest shareholders—SCP Select All Enterprise (Monaco) and SCP Red 5 Solutions (Monaco)—will not participate in the secondary offering and are expected to remain subject to resale restrictions. Maintaining the positions of major shareholders could help reinforce ownership stability during the proposed transition to public trading.

Chief Executive Officer Nikogiannis (John) Karantzis said the initiative responds directly to shareholder feedback requesting a simpler method of accessing liquidity before a potential listing. He added that the company intends to balance institutional demand with shareholder selling interest while limiting unnecessary dilution through the primary placement.

Individual shareholders are expected to receive detailed documentation during August 2026 outlining participation procedures, pricing mechanics, and transaction requirements.

The announcement arrives as European equity markets continue to experience gradual recovery following a subdued IPO environment over the past several years. Companies pursuing public listings have increasingly relied on alternative fundraising structures—including private placements, cornerstone investors, and staged capital raises—to improve valuation certainty before entering regulated exchanges.

According to PwC’s Global IPO Watch, European IPO activity has remained selective as companies prioritize valuation stability over accelerated listings. Meanwhile, McKinsey & Company has noted that institutional investors increasingly favor businesses capable of demonstrating disciplined capital allocation and transparent governance before public market entry.

For fintech firms and technology companies, establishing an independently validated reference price before listing may reduce post-listing volatility while improving institutional confidence. Comparable approaches have been observed across European exchanges where issuers seek to build deeper institutional ownership ahead of trading.

From a financial market infrastructure perspective, Xryma’s strategy highlights the growing role of structured liquidity programs within modern capital markets. While the company has not disclosed the expected size of either placement, the process illustrates how issuers are adapting fundraising strategies to balance existing shareholder interests with institutional investment demand.

The announcement does not guarantee that Xryma will ultimately secure admission to Euronext Paris. Regulatory approvals remain outstanding, and the company acknowledged that there can be no assurance regarding either the timing or successful completion of the proposed listing.

For enterprise investors, wealth managers, and capital markets participants, the development underscores broader changes in European listing practices, where valuation transparency, investor alignment, and orderly market formation have become increasingly important components of IPO preparation. As regulatory scrutiny and institutional expectations continue to evolve, structured pre-listing mechanisms may become a more common feature across Europe’s fintech and financial services ecosystem.

Market Landscape

The announcement reflects broader developments across European capital markets, where companies are increasingly combining private placements, institutional book-building, and pre-listing liquidity programs to improve price discovery before public offerings.

Industry analysts note that investors continue to prioritize transparent valuation methodologies and strong governance frameworks amid a cautious IPO environment. As exchanges compete for high-quality listings, issuers are adopting more flexible capital formation strategies that reduce pricing uncertainty while improving liquidity for existing shareholders.

Top Insights

• Xryma plans to reapply for admission to Euronext Paris, using a structured pre-listing liquidity mechanism to establish a market-based valuation before seeking regulatory approval.
• Existing shareholders will receive a voluntary liquidity opportunity, allowing them to sell shares at the same reference price determined through institutional investor participation.
• The pricing process combines private capital raising with secondary share sales, reflecting evolving European capital market practices focused on transparent valuation and orderly trading.
• The transaction depends on sufficient institutional investor demand, highlighting the importance of market validation before companies pursue exchange listings.
• The initiative illustrates broader fintech capital market innovation, where issuers increasingly balance shareholder liquidity, institutional participation, and regulatory expectations.

Get in touch with our fintech expert